Generation of Human Primordial Germ Cell-like Cells at the Surface of Embryoid Bodies from Primed-pluripotency Induced Pluripotent Stem Cells
January 11th, 2019
15.4K views
Primordial germ cells (PGCs) are common precursors of both sperm and eggs. Human embryonic PGCs are specified from pluripotent epiblast cells through interactions of cytokines. Here, we describe a 13-day protocol of inducing human cells transcriptomally resembling PGCs at the surface of embryoid bodies from primed-pluripotency induced pluripotent stem cells.
Overview
This article presents a method for generating human primordial germ cell-like cells (PGCLCs) from primed pluripotency induced pluripotent stem cells (iPSCs) within a 13-day protocol. The technique aims to advance research in human germline toxicology by enabling the study of genomic integrity in PGCs.
Key Study Components
Area of Science
- Neuroscience
- Stem Cell Biology
- Germline Toxicology
Background
- Primordial germ cells (PGCs) are precursors to sperm and eggs.
- Human embryonic PGCs are derived from pluripotent epiblast cells.
- Understanding PGCs is crucial for insights into germline health.
- This study focuses on generating PGCLCs from iPSCs with disease predisposition.
Purpose of Study
- To develop a reliable method for generating human PGCLCs.
- To investigate the effects of genomic damage and repair in PGCs.
- To reduce germline toxicity associated with therapeutic drugs.
Methods Used
- Preparation of extracellular matrix protein-coated plates.
- Inoculation of primed pluripotency iPSCs into culture plates.
- Conversion of iPSCs to naive pluripotent stem cells.
- Formation and maintenance of embryoid bodies (EBs) in culture.
Main Results
- Successful generation of PGCLCs from primed iPSCs within 13 days.
- High cell density and accurate medium changes were critical for success.
- PGCLCs were identified as OCT4-positive cells.
- Method allows for the study of germline toxicity in a controlled environment.
Conclusions
- This protocol provides a valuable tool for studying human germline biology.
- It has implications for understanding and preventing genomic impairment.
- The method can facilitate research into germline toxicology and drug safety.
Frequently Asked Questions
What are primordial germ cells?
Primordial germ cells (PGCs) are the precursors to sperm and eggs, crucial for reproduction.
How long does it take to generate PGCLCs using this method?
The method described allows for the generation of PGCLCs within 13 days.
What is the significance of OCT4 in this study?
OCT4 is a marker used to identify pluripotent stem cells, including PGCLCs.
Why is it important to study germline toxicity?
Studying germline toxicity helps understand the effects of drugs on reproductive health and genomic integrity.
What role do iPSCs play in this research?
Induced pluripotent stem cells (iPSCs) are used as a source to generate PGCLCs for research purposes.
Can this method be applied to study diseases?
Yes, the method can be used to investigate disease predisposition and its effects on germline cells.
Executive Industry Relevance
This protocol enables biopharma R&D to model human germline toxicology using disease-predisposed iPSCs, supporting early mechanistic de-risking of therapeutic compounds. By generating hPGCLCs on EB surfaces within 13 days, teams can assess genomic integrity in a relevant human cell system prior to preclinical investment. The approach provides a scalable, reproducible source of germline-like cells for target validation and safety screening workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of germline-specific pathways and genomic stability mechanisms in a human-relevant context.
- Operational Value: Provides a defined, serum-free differentiation system to reduce variability in early target hypothesis testing.
Screening & Assay Development
- Scientific Value: Generates OCT4+/CD38+ hPGCLCs suitable for FACS-based enrichment and downstream compound screening.
- Operational Value: Yields up to 40-45% enriched hPGCLCs, supporting assay scalability and reproducibility across screening campaigns.
Translational & Preclinical Research
- Scientific Value: Models early human PGC specification to study drug-induced genomic impairment in germline precursors.
- Operational Value: Supports longitudinal culture under rocking, non-adherent conditions for up to 8 days to assess time-dependent toxicological effects.
Pipeline & Workflow Integration
The method fits within the discovery-to-preclinical continuum by providing a germline-relevant system for safety assessment after target identification and before lead optimization.
- Discovery Biology: Supports mechanistic de-risking by modeling human PGC specification from disease-predisposed iPSCs.
- Screening: Enables FACS-based isolation of CD38+ hPGCLCs for quantitative compound exposure studies.
- Analytics: Facilitates OCT4 immunohistochemistry and flow cytometry readouts to measure target engagement and cellular integrity.
- Translational Research: Connects in vitro germline modeling to preclinical evaluation of genomic stability in therapeutic development.
- Enterprise Reuse: Establishes a scalable, protocol-driven system for germline toxicology screening across multiple projects and therapeutic modalities.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in germline toxicity assessment through a defined, reproducible differentiation model.
- Operational Value: Standardizes EB formation and hPGCLC induction via precise timing, density, and medium change parameters.
- Strategic Value: Improves go/no-go decisions by enabling early detection of genomic impairment risks in therapeutic candidates.
- Portfolio Impact: Supports risk-adjusted prioritization by generating human-relevant germline safety data to inform advancement decisions.
Implementation Considerations
- Requires expertise in iPSC culture, embryoid body formation, and flow cytometry for CD38+ enrichment.
- Dependent on low-adherence plasticware, rocking platforms, and consistent medium formulation including BMP4 and 4i reprogramming factors.
- Necessitates strict adherence to cell density (200,000 cells/well) and timing of medium changes to prevent chromosomal aberrations and ensure EB integrity.
- Adaptation considerations include variability in iPSC line responsiveness and the need to avoid prolonged naive pluripotency culture beyond 48 hours.
- Practical limitations include the dependency on precise rocking speed (20 turns/minute) and the inability to maintain EBs beyond 8 days without loss of hPGCLC yield.
Biopharma FAQs
Why does FACS enrichment for CD38+ cells matter for target validation?
FACS enrichment isolates hPGCLCs as CD38+ cells with up to 40-45% yield, enabling pure populations for downstream target engagement and functional assays. This purification step reduces background noise from non-germline cells, improving the specificity of target validation readouts in toxicology screening.
How does independent variable isolation of BMP4 concentration fit the discovery pipeline?
The protocol uses a high concentration of recombinant human BMP4 in the induction medium as a key independent variable to drive PGC-like specification. Isolating this variable allows teams to assess dose-dependent effects on hPGCLC yield and marker expression, supporting mechanistic de-risking in early discovery.
What quantitative dependent variable measurements enable predictive confidence?
OCT4 immunohistochemistry and CD38+ flow cytometry provide quantitative readouts of hPGCLC specification efficiency and purity. These measurements allow teams to establish thresholds for batch consistency and compare conditions across experimental variables, building predictive confidence in model reliability.
Why do replication requirements matter for cross-functional collaboration?
Reproducibility depends on exact cell seeding (200,000 cells/well), timing of medium changes, and rocking speed (20 turns/minute) to avoid chromosomal aberrations and ensure EB formation. Standardizing these parameters enables consistent hPGCLC generation across teams and sites, supporting reliable data transfer in cross-functional projects.
What statistical analysis capabilities are required before implementation?
Teams require the ability to quantify OCT4-positive cell frequency on EB surfaces and CD38+ enrichment yields via FACS to apply statistical comparisons between control and compound-treated conditions. This enables assessment of significant differences in hPGCLC specification or survival, which is essential for evaluating germline toxicity in a statistically rigorous manner.
Chapters in this video
0:04
Title
1:01
Inoculation and Conversion of Primed Pluripotency Human Induced Pluripotent Stem Cells (hiPSCs)
3:40
Embryoid Body (EB) Formation Using Microwell Plates
5:52
Transfer of EBs to Low Attachment Plates and Generation of hPGCLCs on the Surface of EBs
8:00
Immunohistochemical Staining of EBs
9:41
Results: Successful Generation of EBs with hPGCLCs on their Surface
11:29
Conclusion
